Accessibility settings

This paper is in the following e-collection/theme issue:

Reviews on Innovations in Cancer (57) Imaging Informatics (334) Artificial Intelligence (2362) Cancer Prognosis Models and Machine Learning (82) Chemotherapy and Side Effects Management (123) Innovations and Technology in Cancer Care (572) Reviews on Cardiovascular Health and Medicine (35) Cardiac Diagnostics (36) Medical imaging (134) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (230)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63964, first published .
Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review

Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review

Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review

Authors of this article:

Hayat Mushcab1 Author Orcid Image ;   Mohammed Al Ramis2 Author Orcid Image ;   Abdulrahman AlRujaib3 Author Orcid Image ;   Rawan Eskandarani4 Author Orcid Image ;   Tamara Sunbul5 Author Orcid Image ;   Anwar AlOtaibi1 Author Orcid Image ;   Mohammed Obaidan2 Author Orcid Image ;   Reman Al Harbi6 Author Orcid Image ;   Duaa Aljabri7 Author Orcid Image
Article Authors Cited by (10) Tweetations (3) Metrics

Journals

  1. Segura J, Zavaleta E, Jiménez J, Mora K. Opinion paper: artificial intelligence in cardio-oncology: a clinical call to action. Frontiers in Oncology 2025;15 View
  2. Migliari M, Fazzini L, Campana N, Deidda M, Dessì M, Cadeddu Dessalvi C. Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches. Frontiers in Cardiovascular Medicine 2025;12 View
  3. Gianchandani P, Zhang L. The Role of Artificial Intelligence in Cardio-Oncology. Current Cardiovascular Imaging Reports 2025;18(1) View
  4. Lim H, Ryan T, Miller E, Shea E, Bansal N. Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies. Current Treatment Options in Oncology 2026;27(1) View
  5. Maini A, Zaha V. A New Era of Biomarkers in Cardio-Oncology. Current Treatment Options in Cardiovascular Medicine 2026;28(1) View
  6. Oisakede E, Oyedeji O, Olawuyi O, Alabi J, Daniel R, Olawade D. Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed 2026;5:100113 View
  7. Ma Z, Caldwell R, Attia Z, Friedman P, Lerman A, Ng C, Herrmann J. Harnessing artificial intelligence for cardio-oncology:Towards a new future of cardiovascular care for the cancer patient. Trends in Cardiovascular Medicine 2026 View
  8. Afana A, Goncalves T, Toupin S, Pezel T. Artificial intelligence in cardiovascular imaging: current practice in cardio-oncology. Romanian Journal of Cardiology 2026;36(1):19 View
  9. Heydari F, Feli M, Maleknia M, Habibi Z, Sohrabi A, Hamblin M, Naghinezhad J. Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy. Cardiovascular Toxicology 2026;26(3) View
  10. Avagimyan A, Pogosova N, Cardinale D, Fogacci F, Djndoyan Z, Mkrtchyan L, Rezabakhsh A, Cicero A, Faggiano A, Gherbesi E, Carugo S, Taheri M, Bernardi M, Spadafora L, Sasso L, Perone F, Shafie D, Rizzo M, Alizadehasl A, Moudgil R, Sabouret P, Sverdlov A, Prattichizzo F, Ceriello A, Biondi-Zoccai G, Madonna R, De Caterina R, Asteggiano R, Sarrafzadegan N. Diagnostics in cardio-oncology: a focus on anthracyclines. Heart Failure Reviews 2026;31(1) View